Craft

Avecho

Stock Price

$0

2024-10-08

Market Capitalization

$6.3 M

2024-10-08

Revenue

$1.2 M

FY, 2025

Avecho Summary

Company Summary

Overview
Avecho Biotechnology is a biotechnology company developing and commercializing human health and animal health products. It uses its proprietary drug delivery system called Tocopheryl Phosphate Mixture that is derived from vitamin E using a proprietary and patented process that is proven to enhance the solubility and oral, dermal and transdermal absorption of drugs and nutrients.
Type
Public
Status
Active
HQ
Springvale, AU | view all locations
Website
https://avecho.com.au/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Springvale, VIC HQ

    Australia

    a8/2A Westall Rd

Avecho Financials

Summary Financials

Revenue (FY, 2025)
$1.2M
Gross profit (FY, 2025)
$2.9M
Net income (FY, 2025)
($4.4M)
Cash (FY, 2025)
$4.7M
EBIT (FY, 2025)
($4.0M)

Footer menu